Your browser doesn't support javascript.
loading
Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia.
Arima, Nobuyoshi; Kanda, Junya; Tanaka, Junji; Yabe, Toshio; Morishima, Yasuo; Kim, Sung-Won; Najima, Yuho; Ozawa, Yukiyasu; Eto, Tetsuya; Kanamori, Heiwa; Mori, Takehiko; Kobayashi, Naoki; Kondo, Tadakazu; Nakamae, Hirohisa; Uchida, Naoyuki; Inoue, Masami; Fukuda, Takahiro; Ichinohe, Tatsuo; Atsuta, Yoshiko; Kanda, Yoshinobu.
Afiliação
  • Arima N; Department of Hematology, Medical Research Institute Kitano Hospital, Osaka, Japan. Electronic address: n-arima@kitano-hp.or.jp.
  • Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Tanaka J; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
  • Yabe T; Hematology Division, Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
  • Morishima Y; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Kim SW; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Najima Y; Hematology Division, Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
  • Kanamori H; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Mori T; Department of Hematology, Keio University School of Medicine, Tokyo, Japan.
  • Kobayashi N; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Kondo T; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Nakamae H; Department of Hematology, Osaka City University Hospital, Osaka, Japan.
  • Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
  • Inoue M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kanda Y; Devision of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan.
Biol Blood Marrow Transplant ; 24(4): 717-725, 2018 04.
Article em En | MEDLINE | ID: mdl-29197675
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos HLA-C / Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide Aguda / Sistema de Registros / Alelos / Homozigoto Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos HLA-C / Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide Aguda / Sistema de Registros / Alelos / Homozigoto Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article